ABM Stock Price Decreases 12% Since Reporting Q2 Earnings Miss — Negative

ABM   Zacks Investment Research — June 16, 2025

ABM posts mixed second-quarter fiscal 2025 results as earnings fall short of estimates but revenues beat, with segment growth led by aviation and tech solutions.

image for news ABM Stock Price Decreases 12% Since Reporting Q2 Earnings Miss

Carlyle Announces Partnership With Citigroup on Asset-Backed Lending — Positive

C  CG   Zacks Investment Research — June 16, 2025

CG is set to collaborate with C to expand fintech-focused asset-backed finance through a new strategic alliance.

image for news Carlyle Announces Partnership With Citigroup on Asset-Backed Lending

C4 Therapeutics: An Entry Point If There's Ever Going To Be One — Positive

CCCC   Seeking Alpha — June 16, 2025

CCCC's valuation is unjustifiably low, trading at half its liquidity despite a promising pipeline and no imminent cash crisis. Lead candidate cemsidomide shows encouraging early efficacy and tolerability in heavily pretreated multiple myeloma patients, with key data readouts expected in Q3 2025. Cost controls and restructuring have extended CCCC's cash runway into 2027, reducing dilution risk and supporting ongoing development and partnerships.

image for news C4 Therapeutics: An Entry Point If There's Ever Going To Be One

3 Reasons Growth Investors Will Love Stantec (STN) — Positive

STN   Zacks Investment Research — June 16, 2025

Stantec (STN) could produce exceptional returns because of its solid growth attributes.

image for news 3 Reasons Growth Investors Will Love Stantec (STN)

3 Reasons Growth Investors Will Love New Jersey Resources (NJR) — Positive

NJR   Zacks Investment Research — June 16, 2025

New Jersey Resources (NJR) could produce exceptional returns because of its solid growth attributes.

image for news 3 Reasons Growth Investors Will Love New Jersey Resources (NJR)

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=153345&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

image for news Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) Over Securities Violations - Contact Levi & Korsinsky Today

Permian Resources continues to deliver rare growth through strategic, accretive acquisitions. Management's disciplined approach—favoring multiple small, value-accretive deals over large, costly ones—minimizes risk and maximizes upside. The company boasts top-tier acreage and a fortress balance sheet.

image for news Permian Resources: The Growth Story Continues Right Through Market Uncertainty

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / WHY: New York, N.Y., June 16, 2025.

image for news ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ:WOOF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Petco Health And Wellness Company, Inc. - WOOF

Dan Ives on what's inside his AI revolution ETF — Positive

QQQ   CNBC Television — June 16, 2025

Dan Ives, Wedbush Securities, joins CNBC's Dom Chu on ‘Halftime Report' to discuss his new AI revolution ETF, the top holdings and how it stands out from the competition.

image for news Dan Ives on what's inside his AI revolution ETF

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Rocket Companies, Inc. (NYSE:RKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://www.zlk.com/pslra-1/rocket-companies-inc-loss-submission-form?prid=153344&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

image for news Lost Money on Rocket Companies, Inc. (RKT)? Contact Levi & Korsinsky Before July 8, 2025 to Join Class Action

SkyWater Banks on ThermaView Platform to Revive Wafer Services Growth — Positive

SKYT   Zacks Investment Research — June 16, 2025

SKYT rebounds with a 70% jump in Wafer Services revenues as its ThermaView platform gains rapid traction in defense.

image for news SkyWater Banks on ThermaView Platform to Revive Wafer Services Growth

SKYT vs. MRVL: Which Semiconductor Stock is the Better Investment? — Positive

MRVL  SKYT   Zacks Investment Research — June 16, 2025

SkyWater Technology's quantum push, Fab 25 deal and lean valuation stack up strongly against Marvell Technology's AI-fueled momentum.

image for news SKYT vs. MRVL: Which Semiconductor Stock is the Better Investment?

Shares of EchoStar rose as much as 50% on Monday following a late Friday Bloomberg report that U.S. President Donald Trump urged EchoStar Chairman Charlie Ergen and Federal Communications Commission Chair Brendan Carr to reach a deal over the fate of the company's wireless spectrum licenses.

image for news EchoStar soars 50% after report Trump urged EchoStar, FCC chair to reach deal on licenses

Gold (XAUUSD), Silver, Platinum Forecasts – Gold Pulled Back Below $3400 — Negative

AAAU  DGL  DGP  GLD  GLDM  IAU  IAUF  OUNZ  UGL   FXEmpire — June 16, 2025

Gold is losing ground as traders take some profits off the table despite tensions in the Middle East.

image for news Gold (XAUUSD), Silver, Platinum Forecasts – Gold Pulled Back Below $3400

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2025.

image for news ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Vestis Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – VSTS

Novo Nordisk Stock Rises 6% in a Week: What Should Investors Do? — Positive

NVO   Zacks Investment Research — June 16, 2025

NVO jumps nearly 6% in a week on amycretin pipeline boost and hedge fund interest, but competition looms large.

image for news Novo Nordisk Stock Rises 6% in a Week: What Should Investors Do?

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=153343&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) Shareholders of Class Action Lawsuit and July 14, 2025 Deadline

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Gilead Sciences, Inc. ("Gilead" or the "Company") (NASDAQ:GILD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD